What Does Hearts & Science Do?

Total employees1483
HeadquartersCambridge
Founded2016

Hearts-Science is a forward-thinking organization focused on the research, development, and application of cutting-edge technologies and scientific breakthroughs to address critical challenges in cardiovascular health. We are committed to improving patient outcomes by pioneering novel diagnostic tools, therapeutic interventions, and preventative strategies. Our work integrates deep scientific expertise in cardiology with innovative approaches in data science, biomedical engineering, and clinical research to create impactful solutions for heart disease, a leading cause of mortality worldwide. We aim to foster a collaborative environment that brings together leading researchers, clinicians, and industry partners to accelerate the translation of scientific discoveries into tangible benefits for patients and healthcare systems.

Where Is Hearts & Science's Headquarters?

HQ Function

The headquarters serves as the central hub for research and development, strategic planning, corporate administration, and business development activities.

Notable Features:

State-of-the-art laboratory facilities, collaborative workspaces designed to foster innovation, and proximity to leading academic institutions and medical centers.

Work Culture:

The work culture at the Hearts-Science HQ is characterized by a fast-paced, intellectually stimulating environment. Emphasis is placed on scientific rigor, teamwork, open communication, and a shared passion for making a difference in cardiovascular medicine. Employees often engage in cross-functional projects and continuous learning.

HQ Significance:

Its location in a major biotech hub provides Hearts-Science with unparalleled access to a rich ecosystem of research talent, potential collaborators, investors, and cutting-edge technologies, crucial for its mission.

Values Reflected in HQ: The headquarters' design and functionality reflect Hearts-Science's core values of innovation, collaboration, excellence, and patient-centricity.

Location:

Hearts-Science supports its mission through a strategically positioned headquarters in a leading US biotech hub, complemented by regional offices in key markets like California and the UK. These locations facilitate global research collaborations, clinical trial management across diverse populations, engagement with international regulatory bodies, and tailored market access strategies to bring cardiovascular innovations to patients worldwide.

Street Address:

1 Innovation Drive, Suite 200

City:

Cambridge

State/Province:

MA

Country:

USA

Where Else Does Hearts & Science Operate Around the World?

San Diego, CA/USA

Address: 456 BioPharma Ave, Suite 100, San Diego, CA 92121, USA

To manage and expand clinical research activities, engage with Key Opinion Leaders (KOLs) on the West Coast, and explore strategic alliances within the Pacific biotech cluster.

London/UK

Address: 789 HealthTech Row, London, W1G 0JR, UK

To facilitate European market entry, manage regulatory submissions, and build relationships with European healthcare providers and research institutions.

Buying Intent Signals for Hearts & Science

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Hearts & Science? Meet the Executive Team

As of April 2025, Hearts & Science' leadership includes:

Dr. Eleanor Vance - Chief Executive Officer & Co-Founder
Dr. Samuel Greene - Chief Scientific Officer & Co-Founder
Maria Rodriguez - Chief Operating Officer
David Chen - Chief Financial Officer
Dr. Aisha Khan - Chief Medical Officer

Who's Investing in Hearts & Science?

Hearts & Science has been backed by several prominent investors over the years, including:

BioFuture Ventures
CardiaTech Capital
HealthInnovation Fund
AngelMD Syndicate

What Leadership Changes Has Hearts & Science Seen Recently?

Hire2
Exits0

Over the past year, Hearts-Science has strategically strengthened its leadership team with key appointments to drive its next phase of growth and innovation, particularly in clinical development and financial strategy. There were no major executive departures during this period.

New Appointments:

David Chen, David Chen appointed as new CFO, tasked with overseeing financial strategy and investor relations as the company scales.
Dr. Aisha Khan, Dr. Aisha Khan joined as CMO to spearhead clinical development programs and medical affairs.

What Technology (Tech Stack) Is Used byHearts & Science?

Discover the tools Hearts & Science uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Hearts & Science Email Formats and Examples

Hearts-Science typically utilizes a standard professional email format, most commonly combining the first initial and last name, or first name and last name separated by a dot, followed by the company domain.

[first_initial][last]@hearts-science.com OR [first].[last]@hearts-science.com

Format

evance@hearts-science.com or eleanor.vance@hearts-science.com

Example

85%

Success rate

What's the Latest News About Hearts & Science?

BioSpaceFebruary 15, 2024

Hearts-Science Advances Lead Candidate for Heart Failure into Phase II Trials

Hearts-Science announced today the initiation of its Phase II clinical trial for HS-001, a novel therapeutic agent for treating chronic heart failure. The study aims to evaluate the efficacy and safety of HS-001 in a larger patient population....more

FierceBiotechSeptember 5, 2023

Hearts-Science Secures $50M Series B to Fuel Cardiovascular Pipeline

Hearts-Science has successfully closed a $50 million Series B financing round. The funding will be used to advance its lead drug candidate through clinical trials and expand its research platform for discovering new cardiovascular therapies....more

Endpoints NewsMay 20, 2023

Hearts-Science Presents Promising Preclinical Data for Novel Arrhythmia Treatment at Cardiology Conference

Researchers from Hearts-Science presented compelling preclinical data for their innovative approach to treating cardiac arrhythmias at the Annual Cardiology Innovation Summit. The data highlighted significant potential for their HS-002 compound....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Hearts & Science, are just a search away.